X marks the shot against malaria

Raphael A. Reyes, Rolando Garza, Evelien M. Bunnik

Producción científica: Comment/debaterevisión exhaustiva

Resumen

The development of a transmission-blocking vaccine (TBV) against malaria is hampered by poor understanding of functional antibody responses. In this issue of Immunity, Fabra-Garcia et al., Ivanochko et al., and Tang et al. isolate human monoclonal antibodies against the two most promising TBV candidates, Pfs48/45 and Pfs230, and map the epitopes responsible for potent transmission-reducing activity.

Idioma originalEnglish (US)
Páginas (desde-hasta)234-236
Número de páginas3
PublicaciónImmunity
Volumen56
N.º2
DOI
EstadoPublished - feb 14 2023

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Huella

Profundice en los temas de investigación de 'X marks the shot against malaria'. En conjunto forman una huella única.

Citar esto